腺苷
黑色素瘤
发病机制
腺苷受体
信号转导
癌症研究
嘌呤能信号
腺苷A3受体
炎症
医学
受体
生物
药理学
免疫学
细胞生物学
内分泌学
内科学
兴奋剂
作者
Amirhossein Bahreyni,Melika Rezaei,Majid Khazaei,Hamid Fuiji,Gordon A. Ferns,Mikhail Ryzhikov,Amir Avan,Seyed Mahdi Hassanian
标识
DOI:10.1016/j.bcp.2018.09.018
摘要
Melanoma cancer cell proliferation, motility, invasion, and tumor growth is affected by the adenosine pathway that consists of adenosine-synthesizing enzymes, receptors, and their respective agonists/antagonists. Accumulating evidence suggests that ischemia and inflammation, two conditions associated with melanoma, display dysregulated adenosine metabolism, which implicates it as the mechanism responsible for the pathogenesis of melanoma, thereby resulting in advanced diagnosis and therapy. Suppression of adenosine signaling by inhibiting adenosine receptors or adenosine-generating enzymes (CD39 and CD73) on melanoma cells presents a novel therapeutic target for patients with melanoma. This review summarizes the role of adenosine signaling in the pathogenesis of melanoma to advance its understanding and hence improve therapeutics and management.
科研通智能强力驱动
Strongly Powered by AbleSci AI